The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance
Open accessAbstract
Significance: The causes of the sporadic form of Alzheimer’s disease (AD) are unknown. In this study we show that copper (Cu) critically regulates low-density lipoprotein receptor-related protein 1–mediated Aβ clearance across the blood–brain barrier (BBB) in normal mice. Faulty Aβ clearance across the BBB due to increased Cu levels in the aging brain vessels may lead to accumulation of neurotoxic Aβ in brains. In a mouse model of AD low levels of Cu also influences Aβ production and neuroinflammation. Our study suggests that Cu may also increase the severity of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Self-citationThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Self-citationapoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 10×
“Deane R, et al. (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.”
BackgroundInfluentialSelf-citationCu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
The physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 713
Self-citationDeane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58642 · Cited by 619 · cited 7×
“2G) nor in brain capillary levels of APP, β-site APP cleaving enzyme 1 (BACE1), IDE, NEP, very low density lipoprotein receptor (VLDLR), low density lipoprotein receptor (LDLR), receptor for advanced glycation endproducts (RAGE), P-glycoprotein (Pgp), or transferrin receptor in mice treated with and without Cu (Fig.”
BackgroundMethodInfluentialSelf-citationTherapeutics for Alzheimer's Disease Based on the Metal Hypothesis
Bush, A. I., & Tanzi, R. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.001 · Cited by 564
Deane, R., Bell, R., Sagare, A., & Zlokovic, B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 548
Self-citationClearing the brain's amyloid cobwebs
Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519
Prion Protein Selectively Binds Copper(II) Ions
Stöckel, J., Safar, J., Wallace, A. C., Cohen, F. E., & Prusiner, S. B. (1998) · Biochemistry · doi:10.1021/bi972827k · Cited by 518
Copper Binding to the Amyloid-β (Aβ) Peptide Associated with Alzheimer's Disease
Syme, C. D., Nadal, R. C., Rigby, S. E. J., & Viles, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313572200 · Cited by 460
Sparks, D. L., & Schreurs, B. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832769100 · Cited by 459
Copper stimulates proliferation of human endothelial cells under culture
Hu, G.-F. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980601)69:3<326::aid-jcb10>3.0.co;2-a · Cited by 426
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Faux, N. G., Ritchie, C. W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1390 · Cited by 405
Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β
Atwood, C. S., Perry, G., Zeng, H., Kato, Y., Jones, W. D., Ling, K.-Q., Huang, X., Moir, R. D., Wang, D., Sayre, L. M., et al. (2004) · Biochemistry · doi:10.1021/bi0358824 · Cited by 371
Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease
Deane, R., & Zlokovic, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362245 · Cited by 365
Self-citationIdentification of nitrated proteins in Alzheimer’s disease brain using a redox proteomics approach
Sultana, R., Poon, H. F., Cai, J., Pierce, W. M., Merchant, M., Klein, J. B., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.004 · Cited by 364 · cited 1×
“In brains of patients with AD there is widespread protein nitrotyrosination (53, 54).”
BackgroundMaynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. I., & Li, Q.-X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204379200 · Cited by 353
Bayer, T. A., Schäfer, S., Simons, A., Kemmling, A., Kamer, T., Tepests, R., Eckert, A., Schüssel, K., Eikenberg, O., Sturchler-Pierrat, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332818100 · Cited by 327
Cellular Copper Transport and Metabolism
Harris, E. D. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.291 · Cited by 314
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1287 · Cited by 280
Self-citationRole of copper transporters in copper homeostasis
Prohaska, J. R. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.826s · Cited by 272
Copper absorption and bioavailability
Wapnir, R. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.1054s · Cited by 271
Copper transport to the brain by the blood-brain barrier and blood-CSF barrier
Choi, B.-S., & Zheng, W. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.056 · Cited by 250
Copper handling machinery of the brain
Lutsenko, S., Bhattacharjee, A., & Hubbard, A. L. (2010) · Metallomics · doi:10.1039/c0mt00006j · Cited by 244
You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D. T., Lipton, S. A., Stys, P. K., & Zamponi, G. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110789109 · Cited by 243
Elevation of serum copper levels in Alzheimer’s disease
Squitti, R., Lupoi, D., Pasqualetti, P., Dal Forno, G., Vernieri, F., Chiovenda, P., Rossi, L., Cortesi, M., Cassetta, E., & Rossini, P. M. (2002) · Neurology · doi:10.1212/wnl.59.8.1153 · Cited by 239
Metabolism of amyloid-β peptide and Alzheimer's disease
Iwata, N., Higuchi, M., & Saido, T. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.010 · Cited by 220
In vivo reduction of amyloid-β by a mutant copper transporter
Phinney, A. L., Drisaldi, B., Schmidt, S. D., Lugowski, S., Coronado, V., Liang, Y., Horne, P., Yang, J., Sekoulidis, J., Coomaraswamy, J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332851100 · Cited by 205
Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease
Brewer, G. J. (2012) · BioFactors · doi:10.1002/biof.1005 · Cited by 188
Elevated labile Cu is associated with oxidative pathology in Alzheimer disease
James, S. A., Volitakis, I., Adlard, P. A., Duce, J. A., Masters, C. L., Cherny, R. A., & Bush, A. I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.446 · Cited by 183
Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07402.x · Cited by 181
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
Squitti, R., Barbati, G., Rossi, L., Ventriglia, M., Dal Forno, G., Cesaretti, S., Moffa, F., Caridi, I., Cassetta, E., Pasqualetti, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000223343.82809.cf · Cited by 180
BORCHARDT, T., CAMAKARIS, J., CAPPAI, R., MASTERS, C. L., BEYREUTHER, K., & MULTHAUP, G. (1999) · Biochemical Journal · doi:10.1042/bj3440461 · Cited by 171
Treatment of Wilson's disease with zinc
Brewer, G. J. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90213-5 · Cited by 153
Smith, M. A., Richey, P. L., Taneda, S., Kutty, R. K., Lm, S., Monnier, V. M., & Perry, G. L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21836.x · Cited by 152
Brewer, G. J. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719777 · Cited by 149
Low-Density Lipoprotein Receptor Family
Bu, G., Li, Y., & Cam, J. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:1:53 · Cited by 137
Antioxidant Enzymes and Related Trace Elements in Aging Brain Capillaries and Choroid Plexus
Tayarani, I., Cloëz-Tayarani, I., Clément, M., & Bourre, J. M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11778.x · Cited by 135
Taylor, D. R., & Hooper, N. M. (2007) · Biochemical Journal · doi:10.1042/bj20061736 · Cited by 133
Distribution of Copper Among Components of Human Serum 2
Wirth, P. L., & Linder, M. C. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/75.2.277 · Cited by 125
Sparks, D. L., Friedland, R. P., Petanceska, S. S., Schreurs, B. G., Shi, J., Perry, G. L., Smith, M. A., Sharma, A., DeRosa, S., Ziolkowski, C. H. J., et al. (2006) · PubMed · Cited by 112
Copper transport in rats involving a new plasma protein
Weiss, K. C., & Linder, M. C. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.1.e77 · Cited by 112
Deane, R., Zheng, W., & Zloković, B. V. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02221.x · Cited by 107
Self-citationMechanism of copper(II)-induced misfolding of Parkinson's disease protein
Rose, F., Hodak, M., & Bernholc, J. (2011) · Scientific Reports · doi:10.1038/srep00011 · Cited by 88
Treatment of Wilson’s Disease with Zinc II. Validation of Oral 64Copper with Copper Balance
Hill, G. M., Brewer, G. J., Juni, J. E., Prasad, A. S., & Dick, R. D. (1986) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198612000-00002 · Cited by 78
Copper binding to the Alzheimer’s disease amyloid precursor protein
Kong, G. K.-W., Miles, L. A., Crespi, G. A. N., Morton, C. J., Ng, H. L., Barnham, K. J., McKinstry, W. J., Cappai, R., & Parker, M. W. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0234-3 · Cited by 77
Greenough, M. A., Volitakis, I., Li, Q., Laughton, K. M., Evin, G. M., Ho, M., Dalziel, A. H., Camakaris, J., & Bush, A. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163964 · Cited by 76
Hung, Y. H., Robb, E. L., Volitakis, I., Ho, M., Evin, G. M., Li, Q.-X., Culvenor, J. G., Masters, C. L., Cherny, R. A., & Bush, A. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019521 · Cited by 74
Copper Efflux from Murine Microvascular Cells Requires Expression of the Menkes Disease Cu-ATPase
Qian, Y., Tiffany‐Castiglioni, E., Welsh, J., & Harris, E. D. (1998) · Journal of Nutrition · doi:10.1093/jn/128.8.1276 · Cited by 72
Squitti, R. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2012.04.012 · Cited by 64
Deane, R., & Bradbury, M. W. B. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02337.x · Cited by 64
Self-citationCysteine 144 Is a Key Residue in the Copper Reduction by the β‐Amyloid Precursor Protein
Ruiz, F. H., González, M., Bodini, M. E., Opazo, C., & Inestrosa, N. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731288.x · Cited by 54
Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson’s disease
Terwel, D., Löschmann, Y., Schmidt, H., Schöler, H. R., Cantz, T., & Heneka, M. T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07278.x · Cited by 53
Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination
Coma, M., Guix, F. X., Uribesalgo, I., Espuña, G., Solé, M., Andreu, D., & Muñoz, F. J. (2005) · Brain · doi:10.1093/brain/awh492 · Cited by 46
Self-citationYoburn, J. C., Tian, W., Brower, J. O., Nowick, J. S., Glabe, C. G., & Vranken, D. L. V. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025666g · Cited by 39
Bayer, T. A., & Multhaup, G. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8212 · Cited by 33
Chutkow, J. G. (1978) · Experimental Biology and Medicine · doi:10.3181/00379727-158-40152 · Cited by 25
Characterization of a Schwann cell enhancer in the myelin basic protein gene
Taveggia, C., Pizzagalli, A., Fagiani, E., Messing, A., Feltri, M. L., & Wrabetz, L. G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02745.x · Cited by 19
Cited by
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Wilson's disease and other neurological copper disorders
Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70190-5 · Cited by 1,036
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease
Peng, W., Achariyar, T. M., Li, B., Liao, Y., Mestre, H., Hitomi, E., Regan, S., Kasper, T., Peng, S., Ding, F., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.015 · Cited by 580
Self-citation
Metadata
- Authors
- Singh, I., Sagare, A. P., Coma, M., Perlmutter, D., Gelein, R., Bell, R. D., Deane, R. J., Zhong, E., Parisi, M., Ciszewski, J., Kasper, R. T., & Deane, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-08-19
- Volume
- 110
- Issue
- 36
- Pages
- 14771-14776
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2053351407
- Cited by
- 254
- References
- 66
- FWCI
- 15.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.